These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23678532)

  • 1. [Cardiac resynchronization therapy in women].
    Lunati M; Landolina M; Cipriani M; Rordorf R; Bisetti S; Campo C; Ghio S; Frigerio M
    G Ital Cardiol (Rome); 2012 May; 13(5 Suppl 1):31S-34S. PubMed ID: 23678532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paced left ventricular QRS width and ECG parameters predict outcomes after cardiac resynchronization therapy: PROSPECT-ECG substudy.
    Hsing JM; Selzman KA; Leclercq C; Pires LA; McLaughlin MG; McRae SE; Peterson BJ; Zimetbaum PJ
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):851-7. PubMed ID: 21956038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac resynchronization therapy: do women benefit more than men?
    Xu YZ; Friedman PA; Webster T; Brooke K; Hodge DO; Wiste HJ; Hua W; Zhang S; Hayes DL; Cha YM
    J Cardiovasc Electrophysiol; 2012 Feb; 23(2):172-8. PubMed ID: 21914024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee.
    Stevenson WG; Hernandez AF; Carson PE; Fang JC; Katz SD; Spertus JA; Sweitzer NK; Tang WH; Albert NM; Butler J; Westlake Canary CA; Collins SP; Colvin-Adams M; Ezekowitz JA; Givertz MM; Hershberger RE; Rogers JG; Teerlink JR; Walsh MN; Stough WG; Starling RC;
    J Card Fail; 2012 Feb; 18(2):94-106. PubMed ID: 22300776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyssynchrony, contractile function, and response to cardiac resynchronization therapy.
    Knappe D; Pouleur AC; Shah AM; Cheng S; Uno H; Hall WJ; Bourgoun M; Foster E; Zareba W; Goldenberg I; McNitt S; Pfeffer MA; Moss AJ; Solomon SD;
    Circ Heart Fail; 2011 Jul; 4(4):433-40. PubMed ID: 21602574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT).
    Martin DT; McNitt S; Nesto RW; Rutter MK; Moss AJ
    Circ Heart Fail; 2011 May; 4(3):332-8. PubMed ID: 21350054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of implantable cardioverter defibrillators and cardiac resynchronization therapy in heart failure.
    Freeman JV; Masoudi FA
    Heart Fail Clin; 2013 Jan; 9(1):59-77. PubMed ID: 23168318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
    Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac resynchronization therapy in patients with intrinsic and right ventricular pacing-induced left bundle branch block pattern.
    Shen X; Aronow WS; Holmberg MJ; Li H; Nair CK; Korlakunta H; Esterbrooks DJ
    Am J Ther; 2009; 16(6):e44-50. PubMed ID: 19940605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac resynchronization and quality of life in patients with minimally symptomatic heart failure.
    Veazie PJ; Noyes K; Li Q; Hall WJ; Buttaccio A; Thevenet-Morrison K; Moss AJ
    J Am Coll Cardiol; 2012 Nov; 60(19):1940-4. PubMed ID: 23062542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of outcomes for patients with nonischemic cardiomyopathy taking intravenous inotropes versus those weaned from or never taking inotropes at cardiac resynchronization therapy.
    Adelstein E; Bhattacharya S; Simon MA; Gorcsan J; Saba S
    Am J Cardiol; 2012 Sep; 110(6):857-61. PubMed ID: 22681865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Male gender and chronic obstructive pulmonary disease predict a poor clinical response in patients undergoing cardiac resynchronisation therapy.
    Kirubakaran S; Ladwiniec A; Arujuna A; Ginks M; McPhail M; Bostock J; Carr-White G; Rinaldi CA
    Int J Clin Pract; 2011 Mar; 65(3):281-8. PubMed ID: 21314865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
    Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC;
    Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.
    Gold MR; Thébault C; Linde C; Abraham WT; Gerritse B; Ghio S; St John Sutton M; Daubert JC
    Circulation; 2012 Aug; 126(7):822-9. PubMed ID: 22781424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
    Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Greater response to cardiac resynchronization therapy in patients with true complete left bundle branch block: a PREDICT substudy.
    Perrin MJ; Green MS; Redpath CJ; Nery PB; Keren A; Beanlands RS; Birnie DH
    Europace; 2012 May; 14(5):690-5. PubMed ID: 22170897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
    J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Commentary on the 2010 ESC guidelines on device therapy in heart failure ].
    Israel CW; Anker SD; Hasenfuss G;
    Herzschrittmacherther Elektrophysiol; 2012 Mar; 23(1):33-7. PubMed ID: 22456701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of long-term survival of men versus women with heart failure treated with cardiac resynchronization therapy.
    Mooyaart EA; Marsan NA; van Bommel RJ; Thijssen J; Borleffs CJ; Delgado V; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2011 Jul; 108(1):63-8. PubMed ID: 21529733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.